Kadcyla - Drug Details
๐Ÿ“Š Estimates Kadcyla Dialyzability By Different_Modalities

Kadcyla

Complete Drug Information

Drug Name
Kadcyla
Trade Names
Kadcyla
Pregnancy Category
AU: D
Bioavailability
N/A
Routes of Administration
Intravenous infusion
Protein Binding
93% (in vitro)%
Metabolism
Liver (CYP3A4/3A5-mediated)
Elimination
4 days
Formula
C6448H9948N1720O2012S44ยท(C47H62ClN4O13S)n[citation needed]
Molar Mass
148500
Drug Class
Antineoplastic agent
Volume of Distribution
C6448H9948N1720O2012S44ยท(C47H62ClN4O13S)n[citation needed]

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.